Up to a third of people with type 2 diabetes not taking prescriptions properly
Leicester researchers have used a unique screening approach to suggest that nearly a third of people with type 2 diabetes may be putting their health at risk because they are not taking their medications correctly.
The researchers from the National Centre for Drug Adherence Testing (NCAT) at Leicester’s Hospitals, together with colleagues at the University of Leicester, took urine samples from 228 patients taken at their annual diabetes review. The urine samples were screened for 60 different medicines used to treat type 2 diabetes, heart conditions and high blood pressure (hypertension).
Researchers found that 28.1 per cent (n=64) of this group had either taken none or only some of their medicines.
Dr Prashanth Patel, a consultant and co-director of NCAT at Leicester’s Hospitals, and study co-author, said:
“These findings had a knock-on effect, as those who had not been taking their prescription drugs regularly had significantly higher blood sugar levels compared with those who had been.
“We also found they were more prone to higher levels of microalbumin, a marker that the kidneys may not be healthy, as well as higher blood pressure and more fat levels in the blood, otherwise known as the lipid profile.”
Failing to take prescription drugs properly is called non-adherence. This is problematic because, if not managed correctly, type 2 diabetes can lead to further health complaints, such as kidney disease, limb amputation and cardiovascular problems.
People are also more likely to be admitted to hospital with their poor health and in extreme cases, they could even die.
Study author Dr Pankaj Gupta, a consultant metabolic physician at Leicester’s Hospitals, said:
“The National Centre for Drug Adherence Testing is the first and largest adherence testing centre in the world. We use liquid chromatography-tandem mass spectrometry (LC-MS/MS), to objectively and robustly detect non-adherence for a range of medicines. The benefit of using this technique is it reduces the need for doctors to rely on patients’ self-reporting.”
Professor Kamlesh Khunti, who is Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester and is also a Co-Director at the Leicester Diabetes Centre, said:
“It is difficult to diagnose non-adherence reliably through conversation alone. Many patients may not want to admit that they forget to take their medication, or for whatever reason choose not to, but it is important doctors have the full picture.
“Our study shows, for the first time, that a routine, non-invasive urine sample that’s taken during a standard annual diabetes review can be used to detect the person’s approach to their medication.
“If carried out, this test could help initiate a discussion about the reasons for non-adherence and ways to overcome them. Our findings also show that not taking the right medication correctly is associated with poor diabetes control, which can lead to serious health complications in the future.
“We want to use this research as a way of telling people that if they’re given prescription drugs by their doctor they should take them properly. If they wish to make any changes to their medication or have any worries, then this should be discussed with their healthcare team.”
The authors acknowledge that a weakness of the study is that urine samples only provide a snapshot of non-adherence and more research is needed to confirm whether biochemical testing using LC-MS/MS is a predictor of longer-term outcomes. Further research could also compare biochemical testing against patient self-reported measures of adherence or prescription refill rate.
The study, ‘Biochemical Urine Testing of Adherence to Cardiovascular Medications Reveals High Rates of Nonadherence in People Attending Their Annual Review for Type 2 Diabetes’, is published in Diabetes Care.
Notes to editors
*What do these labels mean? Find out more at https://www.sciencemediacentre.org/wp-content/uploads/2018/01/AMS-press-release-labelling-system-GUIDANCE.pdf
For more information:
Rachael Dowling
Research Communications Manager
Leicester’s Hospitals
0116 258 4971 / 07950 891193
rachael.dowling@uhl-tr.nhs.ukUniversity Hospitals of Leicester NHS Trust is one of the biggest and busiest NHS Trusts in the country, serving the one million residents of Leicester, Leicestershire and Rutland – and increasingly specialist services over a much wider area. Our nationally and internationally-renowned specialist treatment and services in cardio-respiratory diseases, ECMO, cancer and renal disorders reach a further two to three million patients from across the UK.
Spread over the General, Glenfield and Royal Infirmary hospitals, we also have our very own Children’s Hospital and work closely with partners at the University of Leicester and De Montfort University providing world-class teaching to nurture and develop the next generation of over 15,000 highly skilled staff including doctors, nurses and other healthcare professionals, many of whom go on to spend their working lives with us.
For further information, please visit www.leicestershospitals.nhs.uk
NCAT is based at University Hospitals of Leicester NHS Trust. For more information email NCAT@uhl-tr.nhs.uk
About the University of Leicester
The University of Leicester is led by discovery and innovation – an international centre for excellence renowned for research, teaching and broadening access to higher education. It is among the top 25 universities in the Times Higher Education REF Research Power rankings with 75% of research adjudged to be internationally excellent with wide-ranging impacts on society, health, culture, and the environment. The University is home to just over 20,000 students and approximately 3,000 staff.
Find out more: https://le.ac.uk/about
Our Centenary
On 11 November 2018 (Armistice Day), the University of Leicester marked 100 years since the end of the First World War. This date also marks the beginning of the story to create a university in Leicester as a living memorial to honour those who made sacrifices during the Great War. This is reflected in the University's motto Ut vitam habeant – 'so that they may have life'. The University was founded as Leicester, Leicestershire and Rutland University College in 1921. This short film tells the story of our founding.
Out of this World Research
Research scientists at the University of Leicester have a long and distinguished record of discovery in space science. Every single year since 1967 has seen a Leicester-built instrument operating in space. We hold, and have held, vital roles in many space missions for space agencies including the recent BepiColombo mission to Mercury. The University is a partner in Space Park Leicester – a new hub for the analysis and commercialisation of space-enabled data and space mission development.